Chronos Archive seal
The Human Record

Irène Joliot-Curie

Case HR-RB003-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
September 12, 1897 – March 17, 1956
Synthetic DOB
1897-09-12
Index visit
1955-09-14 at age 58
Synthetic MRN
HR-RB003-SYN-TD

Teaching objective: Recognize acute myeloid leukemia in a 58-year-old physicist whose tiredness, bruising and bleeding gums come with pancytopenia and blasts on the smear, and care for it on the NCCN AML guideline and the ELN 1951 recommendations: same-week hematology review with coagulation tests to exclude acute promyelocytic leukemia; bone marrow biopsy with flow cytometry, cytogenetics and molecular testing; classification by both the WHO 1951 and ICC 1951 systems and ELN 1951 genetic risk, deciding how to describe leukemia after occupational rather than therapeutic radiation; a fitness assessment (performance status, comorbidity, lung function after old tuberculosis); azacitidine with venetoclax for a patient unfit for intensive induction, with the dose reduced for posaconazole and tumor lysis precautions; transfusion support with irradiated products; antifungal, antiviral and antibacterial prophylaxis and a febrile neutropenia plan; response assessment at the day-22 marrow and count recovery; early evaluation for allogeneic stem cell transplant; specialist palliative care from the start; and an occupational health history that asks for her dose records, records the employer's duty to keep and release them, and documents a laboratory accident with a polonium source.

Historical timeline

DateEventClaims
September 12, 1897Born in Paris.CLM-0001
1914Nurse radiographer with mobile X-ray units in the First World War.CLM-0002
1925Doctorate on the alpha rays of polonium; married Frédéric Joliot the next year.CLM-0003, CLM-0006
July 4, 1934Death of her mother from aplastic anemia attributed to radiation.CLM-0016
1935Nobel Prize in Chemistry with Frédéric Joliot.CLM-0004, CLM-0007
1936Undersecretary of State for Scientific Research; professor from 1937.CLM-0005
1944Recovering from tuberculosis in Switzerland during the war.CLM-0008
1946Director of the Radium Institute; a polonium capsule exploded on her bench.CLM-0009, CLM-0010
1950Visible decline in her health from shortly after this year.CLM-0013
1956Mountain stay without improvement.CLM-0014
March 17, 1956Died of leukemia in Paris; her leukemia is attributed to occupational radiation.CLM-0011, CLM-0012, CLM-0015

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Irène Curie was born in Paris on 12 September 1897, the elder daughter of the physicist Pierre Curie and his wife, a physicist who also worked with radioactive materials. confirmed Irène Joliot-Curie – Biographical (from Nobel Lectures, Chemistry 1922-1941) supports
Irène Joliot-Curie (1897-1956) supports
HISTMED Master Roster v3 context
D During the First World War she served as a nurse radiographer, operating X-ray machines in mobile field hospitals alongside her mother.
Start of her occupational exposure to ionizing radiation; anchors the modern occupational history.
confirmed Irène Joliot-Curie – Biographical (from Nobel Lectures, Chemistry 1922-1941) supports
Irene Joliot-Curie (profile) supports
Scientist of the Day: Irène Joliot-Curie supports
D She became a Doctor of Science in 1925 with a thesis on the alpha rays of polonium, and in 1926 married Frédéric Joliot; the couple joined their surnames and worked together on natural and artificial radioactivity and nuclear physics.
Anchors decades of laboratory work with polonium and other radioactive sources.
confirmed Irène Joliot-Curie – Biographical (from Nobel Lectures, Chemistry 1922-1941) supports
Irène Joliot-Curie (1897-1956) supports
D In 1935 she and Frédéric Joliot shared the Nobel Prize in Chemistry for their synthesis of new radioactive elements, after showing that bombarding aluminum foil with alpha particles produced artificial radioactivity.
Anchors the modern work history.
confirmed Irène Joliot-Curie – Biographical (from Nobel Lectures, Chemistry 1922-1941) supports
Irène Joliot-Curie (1897-1956) supports
Irene Joliot-Curie (profile) supports
D In 1936 she was appointed Undersecretary of State for Scientific Research; she became a professor in the Faculty of Science in Paris in 1937, and her research on the action of neutrons on heavy elements in 1938 was an important step toward the discovery of nuclear fission.
Background only.
confirmed Irène Joliot-Curie – Biographical (from Nobel Lectures, Chemistry 1922-1941) supports
Irène Joliot-Curie (1897-1956) supports
D She and Frédéric Joliot had a daughter and a son.
Documented history only; the children are not named and play no part in the modern episode.
confirmed Irène Joliot-Curie – Biographical (from Nobel Lectures, Chemistry 1922-1941) supports
D She had always been of unstable health, and the couple took regular trips to the countryside to help her condition.
Background for the modern history.
probable Irène Joliot-Curie (Science, civilization and society, lecture 29 illustrations) supports
D During the Second World War she spent time in Switzerland recovering from tuberculosis, and in 1944 brought her children with her to Switzerland.
Anchors the modern history of treated pulmonary tuberculosis and the reduced lung gas transfer found on testing.
probable Irene Joliot-Curie (profile) supports
D In 1946 she became director of the Radium Institute; as a commissioner for atomic energy for six years she took part in building the first French atomic pile in 1948, and she drew up the plans for the large nuclear physics center at Orsay.
Anchors the modern work history as a laboratory director.
confirmed Irène Joliot-Curie (1897-1956) supports
D In 1946 a capsule of polonium exploded on her laboratory bench.
Anchors the modern history of a sealed-source accident in her laboratory; no dose estimate from the incident is documented.
probable Zielinski S. Six Secrets of Polonium supports
R Smithsonian magazine reported that the 1946 polonium accident is thought to have possibly been responsible for her death from leukemia ten years later, and that she may have been the first person to die of polonium poisoning.
Retrospective interpretation; the modern episode records the accident as part of an occupational history and does not attribute the leukemia to one event.
possible Zielinski S. Six Secrets of Polonium supports
R Her leukemia is usually attributed to over-exposure to X-rays during the First World War and to radioactive materials during her life of research.
Retrospective interpretation, widely repeated; why the modern episode takes an occupational radiation history and treats the leukemia as exposure-related.
probable Scientist of the Day: Irène Joliot-Curie supports
Irène Joliot-Curie (1897-1956) supports
Irene Joliot-Curie (profile) supports
D Shortly after 1950 her health declined visibly.
Anchors the timing of the index visit and the synthetic presenting illness.
probable Irène Joliot-Curie (Science, civilization and society, lecture 29 illustrations) supports
D A stay in the mountains in 1956 brought no improvement, and she died of leukemia shortly after.
After the index date; recorded as history. No modern visit is placed in 1956 in the true frame.
probable Irène Joliot-Curie (Science, civilization and society, lecture 29 illustrations) supports
D She died of leukemia in Paris on 17 March 1956, at the age of 58.
History only; the type of leukemia is not stated in the cited sources, and the modern subtype is synthetic.
confirmed Irène Joliot-Curie – Biographical (from Nobel Lectures, Chemistry 1922-1941) supports
Irène Joliot-Curie (1897-1956) supports
Scientist of the Day: Irène Joliot-Curie supports
Irene Joliot-Curie (profile) context
D Her mother died on 4 July 1934; the director of the sanatorium where she died reported an aplastic pernicious anemia of rapid, feverish development, in which the bone marrow did not react, probably because it had been injured by a long accumulation of radiations.
Family history: bone marrow failure attributed to radiation in a parent who worked with radioactive materials.
confirmed The Radium Institute (1919-1934), online exhibit supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Two months of tiredness, easy bruising and bleeding gums, with pancytopenia and 12 percent blasts on the blood smear; acute leukemia suspected and urgent hematology review booked resolved confirmed active CLM-0013
S Acute myeloid leukemia diagnosed on bone marrow biopsy (34 percent myeloblasts), in a physicist with decades of occupational exposure to ionizing radiation; synthetic modern diagnosis linked to her documented leukemia active confirmed both_with_link CLM-0011, CLM-0012, CLM-0015
S Occupational exposure to ionizing radiation over about four decades: X-ray work early in her career, laboratory work with polonium and other radioactive sources, and a laboratory accident in which a sealed polonium source ruptured on her bench about ten years ago active confirmed both_with_link CLM-0002, CLM-0003, CLM-0010
S Pulmonary tuberculosis in her forties, treated to completion; no symptoms of active disease active confirmed both_with_link CLM-0008
S Moderately reduced lung gas transfer (DLCO 58 percent of predicted, FEV1 76 percent) from old tuberculous scarring of the right upper lobe; with performance status 2, it makes her unfit for intensive induction active confirmed active CLM-0008
S Nausea with vomiting and constipation on day 11 of cycle 1 of azacitidine with venetoclax, without fever, with mild low potassium; managed as an outpatient; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1955-09-14 Leukocytes [#/volume] in Blood by Automated count 2.1 10*3/uL (low)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1955-09-14 Neutrophils [#/volume] in Blood by Automated count 0.6 10*3/uL (low)
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 1955-09-14 Hemoglobin [Mass/volume] in Blood 8.4 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1955-09-14 MCV [Entitic mean volume] in Red Blood Cells by Automated count 104 fL (high)
Reference 80-100 fL
http://loinc.org · 787-2
S 1955-09-14 Platelets [#/volume] in Blood by Automated count 38 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1955-09-14 Blasts/Leukocytes in Blood by Manual count 12% (high)
Reference None seen normally
http://loinc.org · 709-6
S 1955-09-14 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1955-09-14 Potassium [Moles/volume] in Serum or Plasma 4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1955-09-14 Creatinine [Mass/volume] in Serum or Plasma 0.78 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1955-09-14 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M 88 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1955-09-14 Calcium [Mass/volume] in Serum or Plasma 9.2 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1955-09-14 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1955-09-14 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1955-09-14 Albumin [Mass/volume] in Serum or Plasma 3.9 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 1955-09-14 Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma 412 U/L (high)
Reference 140-280 U/L
http://loinc.org · 2532-0
S 1955-09-14 Urate [Mass/volume] in Serum or Plasma 6.4 mg/dL (high)
Reference 2.6-6 mg/dL
http://loinc.org · 3084-1
S 1955-09-14 ECOG Performance Status score 1 http://loinc.org · 89247-1
S 1955-09-14 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 1955-09-16 Leukocytes [#/volume] in Blood by Automated count 1.9 10*3/uL (low)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1955-09-16 Neutrophils [#/volume] in Blood by Automated count 0.5 10*3/uL (low)
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 1955-09-16 Hemoglobin [Mass/volume] in Blood 7.1 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1955-09-16 Platelets [#/volume] in Blood by Automated count 22 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1955-09-16 Blasts/Leukocytes in Blood by Manual count 14% (high)
Reference None seen normally
http://loinc.org · 709-6
S 1955-09-16 Blasts/cells in Bone marrow 34% (high)
Reference Below 5% normally; 20% or more defines AML
http://loinc.org · 11150-0
S 1955-09-16 INR in Platelet poor plasma by Coagulation assay 1.1
Reference 0.8-1.2
http://loinc.org · 6301-6
S 1955-09-16 Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay 310 mg/dL
Reference 200-400 mg/dL
http://loinc.org · 3255-7
S 1955-09-28 Leukocytes [#/volume] in Blood by Automated count 1.6 10*3/uL (low)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1955-09-28 Neutrophils [#/volume] in Blood by Automated count 0.4 10*3/uL (low)
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 1955-09-28 Hemoglobin [Mass/volume] in Blood 8.6 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1955-09-28 Platelets [#/volume] in Blood by Automated count 18 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1955-09-28 Blasts/Leukocytes in Blood by Manual count 16% (high)
Reference None seen normally
http://loinc.org · 709-6
S 1955-09-28 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1955-09-28 Potassium [Moles/volume] in Serum or Plasma 4.1 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1955-09-28 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1955-09-28 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M 85 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1955-09-28 Calcium [Mass/volume] in Serum or Plasma 9.1 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1955-09-28 Phosphate [Mass/volume] in Serum or Plasma 3.6 mg/dL
Reference 2.5-4.5 mg/dL
http://loinc.org · 2777-1
S 1955-09-28 Urate [Mass/volume] in Serum or Plasma 5.8 mg/dL
Reference 2.6-6 mg/dL
http://loinc.org · 3084-1
S 1955-09-28 Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma 448 U/L (high)
Reference 140-280 U/L
http://loinc.org · 2532-0
S 1955-09-28 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1955-09-28 Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1955-09-28 Diffusion capacity.carbon monoxide/Predicted 58% (low)
Reference 80% of predicted or more
http://loinc.org · 98130-8
S 1955-09-28 FEV1 measured/predicted 76% (low)
Reference >=80%
http://loinc.org · 20152-5
S 1955-09-28 Left ventricular Ejection fraction 62%
Reference 55-70%
http://loinc.org · 10230-1
S 1955-09-28 Q-T interval corrected 428 ms
Reference Above 460 ms is prolonged in women
http://loinc.org · 8636-3
S 1955-09-28 ECOG Performance Status score 2 http://loinc.org · 89247-1
S 1955-09-28 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 8 http://loinc.org · 44261-6
S 1955-09-28 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 8 http://loinc.org · 70274-6
S 1955-10-19 Leukocytes [#/volume] in Blood by Automated count 0.6 10*3/uL (low)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1955-10-19 Neutrophils [#/volume] in Blood by Automated count 0.2 10*3/uL (low)
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 1955-10-19 Hemoglobin [Mass/volume] in Blood 8.9 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1955-10-19 Platelets [#/volume] in Blood by Automated count 31 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1955-10-19 Blasts/Leukocytes in Blood by Manual count 0%
Reference None seen normally
http://loinc.org · 709-6
S 1955-10-19 Blasts/cells in Bone marrow 3%
Reference Below 5% normally; 20% or more defines AML
http://loinc.org · 11150-0
S 1955-10-19 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1955-10-19 Potassium [Moles/volume] in Serum or Plasma 3.9 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1955-10-19 Creatinine [Mass/volume] in Serum or Plasma 0.79 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1955-10-19 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M 87 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1955-10-19 Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma 196 U/L
Reference 140-280 U/L
http://loinc.org · 2532-0
S 1955-10-19 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1955-10-30 Leukocytes [#/volume] in Blood by Automated count 2.2 10*3/uL (low)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1955-10-30 Neutrophils [#/volume] in Blood by Automated count 0.9 10*3/uL (low)
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 1955-10-30 Hemoglobin [Mass/volume] in Blood 9.6 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1955-10-30 Platelets [#/volume] in Blood by Automated count 88 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1955-10-30 Blasts/Leukocytes in Blood by Manual count 0%
Reference None seen normally
http://loinc.org · 709-6
S 1955-10-30 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1955-10-30 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1955-10-30 Creatinine [Mass/volume] in Serum or Plasma 0.81 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1955-10-30 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M 84 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1955-10-30 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1955-10-30 ECOG Performance Status score 1 http://loinc.org · 89247-1
S 1955-10-30 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1955-10-08 Leukocytes [#/volume] in Blood by Automated count 0.7 10*3/uL (low)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1955-10-08 Neutrophils [#/volume] in Blood by Automated count 0.1 10*3/uL (low)
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 1955-10-08 Hemoglobin [Mass/volume] in Blood 7.4 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1955-10-08 Platelets [#/volume] in Blood by Automated count 9 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1955-10-08 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1955-10-08 Potassium [Moles/volume] in Serum or Plasma 3.3 mmol/L (low)
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1955-10-08 Creatinine [Mass/volume] in Serum or Plasma 0.84 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1955-10-08 Magnesium [Mass/volume] in Serum or Plasma 1.8 mg/dL
Reference 1.7-2.2 mg/dL
http://loinc.org · 19123-9
S 1955-10-08 Q-T interval corrected 446 ms
Reference Above 460 ms is prolonged in women
http://loinc.org · 8636-3
S 1955-10-26 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1955-10-26 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 http://loinc.org · 70274-6
S 1955-10-26 Total score [AUDIT-C] 1 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
1955-09-14Body height163 cm8302-2S
1955-09-14Body weight54 kg29463-7S
1955-09-14Body mass index (BMI) [Ratio]20.3 kg/m239156-5S
1955-09-14Systolic blood pressure118 mm[Hg]8480-6S
1955-09-14Diastolic blood pressure70 mm[Hg]8462-4S
1955-09-14Heart rate96 /min8867-4S
1955-09-14Respiratory rate16 /min9279-1S
1955-09-14Body temperature37.2 Cel8310-5S
1955-09-14Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1955-09-16Body height163 cm8302-2S
1955-09-16Body weight53.8 kg29463-7S
1955-09-16Body mass index (BMI) [Ratio]20.2 kg/m239156-5S
1955-09-16Systolic blood pressure114 mm[Hg]8480-6S
1955-09-16Diastolic blood pressure68 mm[Hg]8462-4S
1955-09-16Heart rate100 /min8867-4S
1955-09-16Respiratory rate18 /min9279-1S
1955-09-16Body temperature37.3 Cel8310-5S
1955-09-16Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1955-09-28Body height163 cm8302-2S
1955-09-28Body weight53.5 kg29463-7S
1955-09-28Body mass index (BMI) [Ratio]20.1 kg/m239156-5S
1955-09-28Systolic blood pressure116 mm[Hg]8480-6S
1955-09-28Diastolic blood pressure70 mm[Hg]8462-4S
1955-09-28Heart rate92 /min8867-4S
1955-09-28Respiratory rate16 /min9279-1S
1955-09-28Body temperature36.9 Cel8310-5S
1955-09-28Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1955-10-19Body height163 cm8302-2S
1955-10-19Body weight52.8 kg29463-7S
1955-10-19Body mass index (BMI) [Ratio]19.9 kg/m239156-5S
1955-10-19Systolic blood pressure110 mm[Hg]8480-6S
1955-10-19Diastolic blood pressure66 mm[Hg]8462-4S
1955-10-19Heart rate90 /min8867-4S
1955-10-19Respiratory rate16 /min9279-1S
1955-10-19Body temperature37 Cel8310-5S
1955-10-19Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1955-10-30Body height163 cm8302-2S
1955-10-30Body weight53.6 kg29463-7S
1955-10-30Body mass index (BMI) [Ratio]20.2 kg/m239156-5S
1955-10-30Systolic blood pressure118 mm[Hg]8480-6S
1955-10-30Diastolic blood pressure72 mm[Hg]8462-4S
1955-10-30Heart rate84 /min8867-4S
1955-10-30Respiratory rate16 /min9279-1S
1955-10-30Body temperature36.8 Cel8310-5S
1955-10-30Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1955-10-08Body height163 cm8302-2S
1955-10-08Body weight52.4 kg29463-7S
1955-10-08Body mass index (BMI) [Ratio]19.7 kg/m239156-5S
1955-10-08Systolic blood pressure106 mm[Hg]8480-6S
1955-10-08Diastolic blood pressure64 mm[Hg]8462-4S
1955-10-08Heart rate98 /min8867-4S
1955-10-08Respiratory rate16 /min9279-1S
1955-10-08Body temperature37.2 Cel8310-5S
1955-10-08Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1955-10-26Body height163 cm8302-2S
1955-10-26Body weight53.2 kg29463-7S
1955-10-26Body mass index (BMI) [Ratio]20 kg/m239156-5S
1955-10-26Systolic blood pressure116 mm[Hg]8480-6S
1955-10-26Diastolic blood pressure70 mm[Hg]8462-4S
1955-10-26Heart rate86 /min8867-4S
1955-10-26Respiratory rate16 /min9279-1S
1955-10-26Body temperature36.8 Cel8310-5S
1955-10-26Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Diagnosis, classification and a treatment decision within two weeks of the first visit1955-09-28completedMarrow two days after the first visit; genetics back and treatment started on day 14
Complete cycle 1 without tumor lysis, invasive fungal infection, or bleeding1955-10-30completedNo tumor lysis; no fever or fungal infection; no bleeding beyond bruising; one outpatient visit for nausea
Remission on the response assessment after cycle 1 (ELN 1951 complete remission, or complete remission with partial hematologic recovery)1955-10-30completedDay-22 marrow blasts 3%; at day 33 neutrophils 0.9 and platelets 88: complete remission with partial hematologic recovery, measurable residual disease positive
Her own goals and values recorded and her symptoms controlled with the palliative care team from the first cycle1955-09-28completedSeen by the palliative care team on day 1; goals recorded; symptoms reviewed at every visit
Her occupational dose records obtained and the exposure history documented1955-10-30activeRecords requested in writing from the employer's radiation safety office; history documented

Interventions

InterventionStatusGuideline
Urgent evaluation of pancytopenia with blasts on the smear: peripheral smear review, comprehensive metabolic panel, LDH and uric acid today; coagulation tests at the hematology visit; no aspirin or anti-inflammatory drugs; go to the emergency department at once for a temperature of 38.0 °C or more, bleeding that does not stop, or new confusion or headachecompletedGL-NCCN-AML-2026
Urgent hematology/oncology consultation within two days for suspected acute leukemia: bone marrow biopsy, classification and treatment plancompletedGL-NCCN-AML-2026
Occupational health history: her work with X-rays, polonium and other sources over about four decades, and the sealed-source accident in her laboratory, documented; written request to the employer's radiation safety office for her dosimetry and bioassay records, which the employer must keep and must furnish on requestcompletedGL-NRC-19-13, GL-OSHA-1910-1096
Transfusion support: irradiated, leukoreduced products; red cells one unit at a time for hemoglobin below 7 to 8 g/dL or symptoms; platelets for a count below 10 x10^3/uL, for bleeding, or before procedures that need themcompletedGL-AABB-RBC-2023, GL-AABB-PLT-2015, GL-NCCN-AML-2026
Pre-treatment work-up: HLA typing for a future transplant, hepatitis B, hepatitis C and HIV testing, chest X-ray because of past tuberculosis, echocardiogram, lung function tests with diffusing capacity, and a dental checkcompletedGL-NCCN-AML-2026, GL-ASCO-HBV-2020
Induction with azacitidine 75 mg/m2 on days 1 to 7 and venetoclax ramped up to 70 mg daily (the dose for use with posaconazole), in 28-day cycles; admitted for the ramp-up with tumor lysis monitoring, allopurinol and fluids; bone marrow at day 21 to 28, holding venetoclax if blasts are below 5% until counts recover; later cycles with 21 days of venetoclaxcompletedGL-NCCN-AML-2026, GL-ELN-AML-2022, GL-VIALE-A-2020
Infection prevention: posaconazole, acyclovir, and levofloxacin while neutrophils are below 0.5; a written fever plan (temperature of 38.0 °C or more: go to the emergency department for antibiotics within one hour); hand hygiene and food safetycompletedGL-NCCN-INFX-2026, GL-ASCO-IDSA-FN-2018
Specialist palliative care alongside treatment from the first cycle: symptoms, prognosis in plain numbers, her goals and values, and advance care planning, reviewed at every visitcompletedGL-ASCO-PALL-2024, GL-NCCN-AML-2026
Allogeneic stem cell transplant evaluation by the transplant center from the first cycle: an unrelated donor search from her HLA typing, reduced-intensity conditioning if she reaches remission, and measurable residual disease monitoringcompletedGL-NCCN-AML-2026, GL-ELN-AML-2022
Nausea and constipation during cycle 1: ondansetron as needed after a normal QTc, with no other QT-prolonging antiemetic; polyethylene glycol and senna by mouth, no rectal medicines while neutropenic; potassium replaced; red cells and platelets given; venetoclax continued with foodcompletedGL-ASCO-ANTIEMETIC-2020, GL-NCCN-AML-2026, GL-AABB-PLT-2015

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Irène Joliot-Curie – Biographical (from Nobel Lectures, Chemistry 1922-1941) NobelPrize.org (Nobel Prize Outreach) biography
SRC-0002 Irène Joliot-Curie (1897-1956) AtomicArchive.com biography
SRC-0003 Irene Joliot-Curie (profile) Atomic Heritage Foundation, National Museum of Nuclear Science and History biography
SRC-0004 Scientist of the Day: Irène Joliot-Curie Linda Hall Library other
SRC-0005 Zielinski S. Six Secrets of Polonium Smithsonian Magazine other
SRC-0006 Irène Joliot-Curie (Science, civilization and society, lecture 29 illustrations) Indian National Centre for Ocean Information Services (course pages) other
SRC-0007 The Radium Institute (1919-1934), online exhibit American Institute of Physics, Center for History of Physics other
SRC-0008 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the classification of leukemia after occupational radiation (not 'post cytotoxic therapy' under WHO 2022), the choice of azacitidine with venetoclax over intensive induction, the venetoclax dose with posaconazole, the transfusion thresholds, and the transplant and palliative care plans.
provenance reviewnot_startedNobel biography, AtomicArchive, the Atomic Heritage Foundation profile, the Linda Hall Library, Smithsonian, an INCOIS course page, and the AIP exhibit logged. Britannica and Wikipedia were not used. The year her tuberculosis began and the dates of her 1956 mountain stay are not documented in the fetched sources.
safe messaging reviewnot_startedHer mother is never named in this record. Her children are not named. No sensitive claims. Her death is recorded as history in one sentence. Prognosis is discussed in the modern episode in plain terms.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.